Participating plans including UnitedHealthcare, Humana, Cigna, CVS Health Aetna, and over 30 Blue Cross Blue Shield entities have committed to: curtailing the number of claims requiring PA, honoring existing PAs for 90 days when patients switch plans, and providing clear explanations for PA determinations including appeals guidance ( [72] )
Retatrutide is a separate investigational molecule
As you said, with GLP-1s, okay, they've been around for 20 years for folks with diabetes, but diabetes is kind of a unique context
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed for type 2 diabetes management and, more recently, for weight management in adults with obesity